截至2025年8月4日15时，悦心健康最新股价为4.62元，较前一交易日上涨0.14元。当日开盘价为4.44 元，最高触及4.65元，最低下探4.37元，成交量为60.39万手，成交金额达2.74亿元。 悦心健康主营业务涉及大健康产业，包括健康管理、医疗服务和养老业务。公司通过整合医疗资源，构 建健康服务体系，为消费者提供全方位的健康管理解决方案。 根据公开信息，8月4日早盘时段，悦心健康股价在9点40分左右出现快速反弹，5分钟内涨幅超过2%， 成交金额达3160.99万元。 资金流向数据显示，8月4日主力资金净流入6615.58万元，占流通市值的1.56%。近五个交易日累计主力 资金净流入4899.85万元，占流通市值的1.15%。 风险提示：市场有风险，投资需谨慎。 来源:金融界 ...

证券之星消息，8月4日家居用品板块较上一交易日上涨0.62%，菲林格尔领涨。当日上证指数报收于 3583.31，上涨0.66%。深证成指报收于11041.56，上涨0.46%。家居用品板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 603226 | 菲林格尔 | 19.37 | 8.88% | 12.47万 | | 2.34亿 | | 920445 | 龙竹科技 | 11.70 | 5.79% | 11.56万 | | + 1.31亿 | | 603389 | *ST亚振 | 24.86 | 4.98% | 1592.8 | 395.97万 | | | 301193 | 家联科技 | 19.38 | 4.87% | - 4.71万 | | 8949.87万 | | 603833 | 欧派家居 | 54.02 | 4.73% | 7.54万 | | 4.00亿 | | 300993 | 玉马科技 | 15.23 | 4.53% | 23.02万 | | 3.4 ...

Core Viewpoint - The company Yueshen Health (002162) reported on August 1 that as of July 31, 2025, it expects to have a total of 65,746 shareholders and 2,145 institutional shareholders [1] Summary by Category - **Shareholder Information** - The total number of shareholders is projected to be 65,746 by July 31, 2025 [1] - The number of institutional shareholders is expected to reach 2,145 by the same date [1]

格隆汇7月31日丨悦心健康(002162.SZ)于投资者互动平台表示，公司无托育服务相关的业务。 ...

Group 1 - The company's stock closed at 4.40 yuan on July 29, down 0.12 yuan or 2.65% from the previous trading day [1] - The stock opened at 4.59 yuan, reached a high of 4.79 yuan, and a low of 4.36 yuan, with a trading range of 9.51% [1] - The total trading volume for the day was 720,205 hands, with a transaction amount of 325 million yuan and a turnover rate of 7.84% [1] Group 2 - The company operates in the health industry, with main products including tiles and negative ion health materials, as well as services in medical care and health management [1] - The company is registered in Shanghai and has a business scope that covers building materials manufacturing and medical services [1] Group 3 - During the morning session on July 29, the company's stock experienced a rapid decline, with a drop of over 2% within the first five minutes before 9:35 AM, and a transaction amount of 103 million yuan at that time [1] - The net outflow of main funds for the day was 14.647 million yuan, accounting for 0.36% of the circulating market value [1]

通过天眼查大数据分析，上海悦心健康集团股份有限公司共对外投资了17家企业，参与招投标项目80 次，知识产权方面有商标信息114条，专利信息435条，此外企业还拥有行政许可43个。 悦心健康最新一期业绩显示，截至2025一季报，公司营业总收入1.96亿元、同比减少11.46%，归属净利 润832.82万元，同比增长36.02%，扣非净利润1210.77万元，同比增长19.56%，流动比率0.853、速动比 率0.641、资产负债率59.54%。 天眼查商业履历信息显示，上海悦心健康集团股份有限公司，成立于1993年，位于上海市，是一家以从 事非金属矿物制品业为主的企业。企业注册资本91970.0965万人民币，实缴资本28450万人民币。公司 法定代表人为李慈雄。 金融界消息 截至2025年7月29日收盘，悦心健康（002162）报收于4.4元，下跌2.65%，换手率7.84%， 成交量72.02万手，成交金额3.25亿元。 资金流向方面，今日主力资金净流出1464.70万元，占比成交额4.51%。其中，超大单净流出414.78万 元、占成交额1.28%，大单净流出1049.92万元、占成交额3.23%，中单净 ...

Core Viewpoint - The company has completed changes to its registered capital and corporate governance structure, including the cancellation of the supervisory board and amendments to its articles of association [2][3]. Group 1: Capital Changes - The company approved a stock option incentive plan, resulting in the exercise of 2,106,665 shares, increasing the total share capital from 920,000,000 shares to 922,106,665 shares [2]. - Following a share buyback of 2,405,700 shares, the total share capital was reduced to 919,700,965 shares, and the registered capital was adjusted accordingly [2][3]. - The company has completed the registration procedures for the changes in registered capital with the Shanghai Municipal Market Supervision Administration [3]. Group 2: Corporate Governance - The company held meetings to approve the cancellation of the supervisory board and the revision of its articles of association [2]. - The changes in corporate governance were officially recorded and the new business license was issued [3].

证券代码：002162 证券简称：悦心健康 公告编号：2025-050 二○二五年七月十八日 1 特此公告。 上海悦心健康集团股份有限公司 董事会 关于完成注册资本工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，不存在虚假 记载、误导性陈述或者重大遗漏。 上海悦心健康集团股份有限公司（以下简称"公司"）分别于 2025 年 5 月 26 日、2025 年 6 月 11 日召开了第八届董事会第十五次会议、2025 年第一次临时股东 大会，审议通过了《关于变更注册资本、取消监事会暨修订<公司章程>及其附件的议 案》。公司 2023 年股票期权激励计划首次授予部分股票期权第一个行权期内（2024 年 5 月 20 日至 2025 年 5 月 16 日），公司激励对象累计行权 2,106,665 股，公司总 股本由 920,000,000 股增加至 922,106,665 股，公司注册资本相应由人民币 920,000,000 元增加至人民币 922,106,665 元。同时，2025 年 5 月 13 日，公司实施 完毕股份回购事项，累计回购公司股份 2,405,700 股，并于 202 ...

Core Viewpoint - Shanghai Yueshen Health Group plans to use surplus reserves of 72.85 million yuan and capital reserves of 141 million yuan, totaling 214 million yuan, to offset cumulative losses, resulting in a significant reduction of its reserves and a nearly 400% drop in net profit for 2024 [1][2][4]. Financial Summary - For 2024, the company reported revenue of 1.204 billion yuan, a year-on-year decrease of 5.79%, and a net profit attributable to shareholders of -147 million yuan, a staggering decline of 393.87% [4]. - The company has experienced negative net profits for three consecutive years, with cumulative losses exceeding 500 million yuan, indicating concerns over its core business's ability to generate profits [4]. - The company's operating cash flow also decreased by 33.48% year-on-year, amounting to 82.23 million yuan [4]. Business Transformation - Yueshen Health, originally focused on ceramic tiles, has been transitioning into the health sector since 2015, with its business now encompassing building materials, health services, and investment property leasing [5]. - The company’s building materials segment primarily focuses on high-end ceramic tile brand "Simik," while its health services include various care systems and training programs [5]. Loss Factors - The primary reasons for the company's losses include a decline in revenue from the ceramic tile business due to reduced market demand, increased competition, and rising costs [3]. - The company has also faced challenges related to the long investment cycle of its health projects and asset impairment losses, which have further exacerbated its financial difficulties [4].

Core Viewpoint - Shanghai Yueshen Health Group Co., Ltd. plans to use surplus reserves to cover losses, as the company reported a significant decline in net profit due to increased market competition and reduced sales prices of its products [1][2]. Group 1: Financial Adjustments - The company intends to utilize a total of 72,853,943.26 yuan from surplus reserves and 141,057,228.79 yuan from capital reserves to offset losses, resulting in a reduction of capital reserves to 176,595,527.02 yuan [1]. - As of December 31, 2024, the company's undistributed profits were reported at -0 yuan, indicating a complete depletion of retained earnings [1]. Group 2: Causes of Loss - The primary reasons for the company's losses include a slight decline in sales and intensified market competition, which led to a decrease in sales prices and gross margins of tile products [2]. - The company has also recognized potential impairment losses on assets, further exacerbating the cumulative loss [2]. Group 3: Notification to Creditors - The company has formally notified creditors of their rights to claim debts or request guarantees within 30 days of receiving the notice, or 45 days from the announcement date if no notice is received [2][3]. - Creditors must submit written requests along with relevant documentation to the company to assert their claims [2][3].